Safety and Interactions of Direct Oral Anticoagulants with Antiarrhythmic Drugs
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Link
http://link.springer.com/article/10.1007/s40264-017-0567-5/fulltext.html
Reference52 articles.
1. Reiffel JA, Weitz JI, Reilly P, Kaminskas E, Sarich T, Sager P, et al. DOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: a cardiac safety research consortium think tank. Cardiac safety research consortium presenters and participants. Am Heart J. 2016;177:74–86.
2. Yeh CH, Hogg K, Weitz JI. Overview of the new oral anticoagulants: opportunities and challenges. Arterioscler Thromb Vasc Biol. 2015;35(5):1056–65.
3. Kundu A, Sardar P, Chatterjee S, Aronow WS, Owan T, Ryan JJ. Minimizing the risk of bleeding with DOACs in the elderly. Drugs Aging. 2016;33(7):491–500.
4. Mekaj YH, Mekaj AY, Duci SB, Miftari EI. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015;24(11):967–77.
5. Gottlieb M, Khishfe B. Idarucizumab for the reversal of dabigatran. Ann Emerg Med. 2017;69(5):554–8.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pre-hospital use of direct oral anticoagulants agents is associated with a lower risk of major bleeding events in critically ill patients: A single academic center experience;Heart & Lung;2023-11
2. Non-Coding RNAs and Gut Microbiota in the Pathogenesis of Cardiac Arrhythmias: The Latest Update;Genes;2023-08-30
3. Association Between Concurrent Use of Amiodarone and DOACs and Risk of Bleeding in Patients With Atrial Fibrillation;The American Journal of Cardiology;2023-01
4. Gut microbiota and cardiac arrhythmia: a pharmacokinetic scope;The Egyptian Heart Journal;2022-12-30
5. Solvent bar microextraction combined with HPLC-DAD and multivariate optimization for simultaneous determination of three antiarrhythmic drugs in human urine and plasma samples;Talanta Open;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3